Eric Madore, MD
Internal Medicine · Tyler, TXNPI 1982678884
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (53.2%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Bayer accounts for 71.8% of it on its own, with 11 other manufacturers making up the rest. 2025 is the largest year on record at $3,930, 4.8 times the $819 reported in 2019. Among internal medicine clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 20 payments — averaging $245.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bayer$4K
- Johnson & Johnson$290
- Amgen$218
- Madrigal Pharmaceuticals$146
- Forte Bio-pharma LLC$125
- Genentech USA, Inc.$124
- plus $478 from 6 others
What the payments were for
- Consulting fees$2,61053%
- Travel & lodging$1764%
- Food & beverage$2,11843%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bayer | 6 | $3,523 |
| Johnson & Johnson | 3 | $290 |
| Amgen(2 entities) | 2 | $218 |
| Madrigal Pharmaceuticals | 1 | $146 |
| Forte Bio-pharma LLC | 1 | $125 |
| Genentech USA, Inc. | 1 | $124 |
| AbbVie | 1 | $123 |
| AstraZeneca | 1 | $112 |
| Vertex | 1 | $92 |
| Mylan Specialty L.p. | 1 | $77 |
| Abbott | 1 | $44 |
| Astellas Pharma US Inc | 1 | $29 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,903 in reported general payments places this provider in the 90th percentile of 7,675 internal medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 13 | $7,842 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 15 | $159 |
| ClopidogrelClopidogrel Bisulfate | 15 | $112 |
| Pantoprazole Sodium | 20 | $102 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 13 | $89 |
| Atorvastatin Calcium | 18 | $53 |
| Tramadol Hcl | 14 | $27 |
| Furosemide | 12 | $24 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Tyler
- Thomas BuzbeeTyler$116K
- Spencer BerthelsenSugar Land$891K
- Hameed AliTemple$773K
- Marc TribbleDallas$693K
- Gary SinclairDallas$599K
- Mohammed Al-NajjarEl Paso$586K
- Han SchmidlyDallas$465K
- Hussein TawbiHouston$365K
- Hans LeeHouston$327K
- Tapan KadiaHouston$311K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.